As expected, in the present study, we indeed observed that supplementary BA and GG indeed substantially mitigated diet-induced atherosclerosis and NASH in LDLR-/- hamsters, suggesting that these 2 compounds could be considered to be applied to the treatment of CHL-associated diseases. Here, LDLR is linked to metabolic dysfunction-associated steatohepatitis.